Telser H[au] - Search Results

Year	Number of Results
2000	1
2002	2
2003	1
2005	1
2008	1
2015	1
2016	1
2018	3
2019	1
2022	3

1

Experience with a colorectal cancer campaign in Swiss pharmacies.

Ruggli M, Stebler D, Gasteiger M, Trottmann M, Hochuli P, Telser H, Vaucher F. Ruggli M, et al. Among authors: telser h. Int J Clin Pharm. 2019 Oct;41(5):1359-1364. doi: 10.1007/s11096-019-00899-z. Epub 2019 Sep 28. Int J Clin Pharm. 2019. PMID: 31564044

2

End-of-life healthcare expenditure: Testing economic explanations using a discrete choice experiment.

Fischer B, Telser H, Zweifel P. Fischer B, et al. Among authors: telser h. J Health Econ. 2018 Jul;60:30-38. doi: 10.1016/j.jhealeco.2018.06.001. Epub 2018 Jun 7. J Health Econ. 2018. PMID: 29906764

3

How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts.

Wieser S, Riguzzi M, Pletscher M, Huber CA, Telser H, Schwenkglenks M. Wieser S, et al. Among authors: telser h. Eur J Health Econ. 2018 Nov;19(8):1149-1161. doi: 10.1007/s10198-018-0963-5. Epub 2018 Feb 22. Eur J Health Econ. 2018. PMID: 29470673 Free article.

4

Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paper.

Brougham M, Schlander M, Telser H, Bakshi S, Sola-Morales O. Brougham M, et al. Among authors: telser h. Expert Rev Pharmacoecon Outcomes Res. 2022 May 5:1-6. doi: 10.1080/14737167.2022.2064847. Online ahead of print. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35400272

5

Physician drug dispensing in Switzerland: association on health care expenditures and utilization.

Trottmann M, Frueh M, Telser H, Reich O. Trottmann M, et al. Among authors: telser h. BMC Health Serv Res. 2016 Jul 8;16:238. doi: 10.1186/s12913-016-1470-y. BMC Health Serv Res. 2016. PMID: 27391118 Free PMC article.

6

Cost trajectories from the final life year reveal intensity of end-of-life care and can help to guide palliative care interventions.

von Wyl V, Telser H, Weber A, Fischer B, Beck K. von Wyl V, et al. Among authors: telser h. BMJ Support Palliat Care. 2018 Sep;8(3):325-334. doi: 10.1136/bmjspcare-2014-000784. Epub 2015 Oct 15. BMJ Support Palliat Care. 2018. PMID: 26470876

7

Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].

Moro D, Schlander M, Telser H, Sola-Morales O, Clark MD, Olaye A, Camp C, Jain M, Butt T, Bakshi S. Moro D, et al. Among authors: telser h. Expert Rev Pharmacoecon Outcomes Res. 2022 Jun;22(4):581-598. doi: 10.1080/14737167.2022.2014324. Epub 2022 Feb 23. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34877915

8

Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective.

Fischer B, Serra A, Telser H. Fischer B, et al. Among authors: telser h. Adv Ther. 2022 Jun;39(6):2717-2730. doi: 10.1007/s12325-022-02123-3. Epub 2022 Apr 13. Adv Ther. 2022. PMID: 35416597 Free PMC article.

9

The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.

Nocera S, Telser H, Bonato D. Nocera S, et al. Among authors: telser h. Dev Health Econ Public Policy. 2003;8:iii-xi, 1-116. Dev Health Econ Public Policy. 2003. PMID: 15027158 No abstract available.

10

Validity and Reliability of Willingness-to-Pay Estimates: Evidence from Two Overlapping Discrete-Choice Experiments.

Telser H, Becker K, Zweifel P. Telser H, et al. Patient. 2008 Dec 1;1(4):283-98. doi: 10.2165/1312067-200801040-00010. Patient. 2008. PMID: 22272996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results